CVE-2025-61940 (GCVE-0-2025-61940)
Vulnerability from cvelistv5 – Published: 2025-12-02 21:07 – Updated: 2025-12-09 17:03| Vendor | Product | Version | CPE status | |
|---|---|---|---|---|
| Mirion Medical | EC2 Software NMIS BioDose |
Affected:
0 , < 23.0
(custom)
Unaffected: 23.0 |
guessed |
{
"containers": {
"adp": [
{
"metrics": [
{
"other": {
"content": {
"id": "CVE-2025-61940",
"options": [
{
"Exploitation": "none"
},
{
"Automatable": "no"
},
{
"Technical Impact": "total"
}
],
"role": "CISA Coordinator",
"timestamp": "2025-12-09T17:03:20.801749Z",
"version": "2.0.3"
},
"type": "ssvc"
}
}
],
"providerMetadata": {
"dateUpdated": "2025-12-09T17:03:27.576Z",
"orgId": "134c704f-9b21-4f2e-91b3-4a467353bcc0",
"shortName": "CISA-ADP"
},
"title": "CISA ADP Vulnrichment"
}
],
"cna": {
"affected": [
{
"defaultStatus": "unaffected",
"product": "EC2 Software NMIS BioDose",
"vendor": "Mirion Medical",
"versions": [
{
"lessThan": "23.0",
"status": "affected",
"version": "0",
"versionType": "custom"
},
{
"status": "unaffected",
"version": "23.0"
}
]
}
],
"credits": [
{
"lang": "en",
"type": "finder",
"value": "Joe Dillon reported these vulnerabilities to Mirion Medical."
}
],
"datePublic": "2025-12-02T17:00:00.000Z",
"descriptions": [
{
"lang": "en",
"supportingMedia": [
{
"base64": false,
"type": "text/html",
"value": "\u003cspan style=\"background-color: rgb(255, 255, 255);\"\u003e\n\n\u003cspan style=\"background-color: rgb(255, 255, 255);\"\u003e\n\n\u003cspan style=\"background-color: rgb(255, 255, 255);\"\u003eNMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.\u003c/span\u003e\n\n\u003c/span\u003e\n\n\u003c/span\u003e"
}
],
"value": "NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection."
}
],
"metrics": [
{
"cvssV4_0": {
"Automatable": "NOT_DEFINED",
"Recovery": "NOT_DEFINED",
"Safety": "NOT_DEFINED",
"attackComplexity": "LOW",
"attackRequirements": "NONE",
"attackVector": "NETWORK",
"baseScore": 8.7,
"baseSeverity": "HIGH",
"exploitMaturity": "NOT_DEFINED",
"privilegesRequired": "LOW",
"providerUrgency": "NOT_DEFINED",
"subAvailabilityImpact": "NONE",
"subConfidentialityImpact": "NONE",
"subIntegrityImpact": "NONE",
"userInteraction": "NONE",
"valueDensity": "NOT_DEFINED",
"vectorString": "CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N",
"version": "4.0",
"vulnAvailabilityImpact": "LOW",
"vulnConfidentialityImpact": "HIGH",
"vulnIntegrityImpact": "HIGH",
"vulnerabilityResponseEffort": "NOT_DEFINED"
},
"format": "CVSS",
"scenarios": [
{
"lang": "en",
"value": "GENERAL"
}
]
},
{
"cvssV3_1": {
"attackComplexity": "LOW",
"attackVector": "NETWORK",
"availabilityImpact": "LOW",
"baseScore": 8.3,
"baseSeverity": "HIGH",
"confidentialityImpact": "HIGH",
"integrityImpact": "HIGH",
"privilegesRequired": "LOW",
"scope": "UNCHANGED",
"userInteraction": "NONE",
"vectorString": "CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L",
"version": "3.1"
},
"format": "CVSS",
"scenarios": [
{
"lang": "en",
"value": "GENERAL"
}
]
}
],
"problemTypes": [
{
"descriptions": [
{
"cweId": "CWE-603",
"description": "CWE-603",
"lang": "en",
"type": "CWE"
}
]
}
],
"providerMetadata": {
"dateUpdated": "2025-12-02T21:07:47.995Z",
"orgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
"shortName": "icscert"
},
"references": [
{
"url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01"
}
],
"solutions": [
{
"lang": "en",
"supportingMedia": [
{
"base64": false,
"type": "text/html",
"value": "\u003cspan style=\"background-color: rgb(255, 255, 255);\"\u003eMirion Medical recommends users update to V23.0 or later. Users with an active support contract should update to the latest version through the software or users can contact \u003c/span\u003e\u003ca target=\"_blank\" rel=\"nofollow\"\u003eMirion Medical support\u003c/a\u003e\u003cspan style=\"background-color: rgb(255, 255, 255);\"\u003e\u0026nbsp;directly.\u003c/span\u003e\n\n\u003cbr\u003e"
}
],
"value": "Mirion Medical recommends users update to V23.0 or later. Users with an active support contract should update to the latest version through the software or users can contact Mirion Medical support\u00a0directly."
}
],
"source": {
"advisory": "ICSMA-25-336-01",
"discovery": "EXTERNAL"
},
"title": "Mirion Medical EC2 Software NMIS BioDose Use of Client-Side Authentication",
"x_generator": {
"engine": "Vulnogram 0.5.0"
}
}
},
"cveMetadata": {
"assignerOrgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
"assignerShortName": "icscert",
"cveId": "CVE-2025-61940",
"datePublished": "2025-12-02T21:07:47.995Z",
"dateReserved": "2025-11-11T20:56:52.843Z",
"dateUpdated": "2025-12-09T17:03:27.576Z",
"state": "PUBLISHED"
},
"dataType": "CVE_RECORD",
"dataVersion": "5.2",
"vulnerability-lookup:meta": {
"epss": {
"cve": "CVE-2025-61940",
"date": "2026-11-13",
"epss": "0.00344",
"percentile": "0.28313"
},
"nvd": {
"cve": {
"affected": [
{
"affectedData": [
{
"defaultStatus": "unaffected",
"product": "EC2 Software NMIS BioDose",
"vendor": "Mirion Medical",
"versions": [
{
"lessThan": "23.0",
"status": "affected",
"version": "0",
"versionType": "custom"
},
{
"status": "unaffected",
"version": "23.0"
}
]
}
],
"source": "ics-cert@hq.dhs.gov"
}
],
"configurations": [
{
"nodes": [
{
"cpeMatch": [
{
"criteria": "cpe:2.3:a:mirion:biodose\\/nmis:*:*:*:*:*:*:*:*",
"matchCriteriaId": "0C792586-2A7A-4497-B711-F56F88E84E34",
"versionEndExcluding": "23.0",
"vulnerable": true
}
],
"negate": false,
"operator": "OR"
}
]
}
],
"cveTags": [],
"descriptions": [
{
"lang": "en",
"value": "NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection."
},
{
"lang": "es",
"value": "NMIS/BioDose V22.02 y versiones anteriores dependen de una cuenta de usuario com\u00fan de SQL Server para acceder a los datos en la base de datos. El acceso de usuario en la aplicaci\u00f3n cliente est\u00e1 restringido por una verificaci\u00f3n de autenticaci\u00f3n de contrase\u00f1a en el software cliente, pero la conexi\u00f3n subyacente de la base de datos siempre tiene acceso. La \u00faltima versi\u00f3n de NMIS/BioDose introduce una opci\u00f3n para usar la autenticaci\u00f3n de usuario de Windows con la base de datos, lo que restringir\u00eda esta conexi\u00f3n de la base de datos."
}
],
"id": "CVE-2025-61940",
"lastModified": "2026-09-25T23:10:00.463",
"metrics": {
"cvssMetricV31": [
{
"cvssData": {
"attackComplexity": "LOW",
"attackVector": "NETWORK",
"availabilityImpact": "LOW",
"baseScore": 8.3,
"baseSeverity": "HIGH",
"confidentialityImpact": "HIGH",
"integrityImpact": "HIGH",
"privilegesRequired": "LOW",
"scope": "UNCHANGED",
"userInteraction": "NONE",
"vectorString": "CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L",
"version": "3.1"
},
"exploitabilityScore": 2.8,
"impactScore": 5.5,
"source": "ics-cert@hq.dhs.gov",
"type": "Secondary"
},
{
"cvssData": {
"attackComplexity": "LOW",
"attackVector": "NETWORK",
"availabilityImpact": "HIGH",
"baseScore": 8.8,
"baseSeverity": "HIGH",
"confidentialityImpact": "HIGH",
"integrityImpact": "HIGH",
"privilegesRequired": "LOW",
"scope": "UNCHANGED",
"userInteraction": "NONE",
"vectorString": "CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H",
"version": "3.1"
},
"exploitabilityScore": 2.8,
"impactScore": 5.9,
"source": "nvd@nist.gov",
"type": "Primary"
}
],
"cvssMetricV40": [
{
"cvssData": {
"Automatable": "NOT_DEFINED",
"Recovery": "NOT_DEFINED",
"Safety": "NOT_DEFINED",
"attackComplexity": "LOW",
"attackRequirements": "NONE",
"attackVector": "NETWORK",
"availabilityRequirement": "NOT_DEFINED",
"baseScore": 8.7,
"baseSeverity": "HIGH",
"confidentialityRequirement": "NOT_DEFINED",
"exploitMaturity": "NOT_DEFINED",
"integrityRequirement": "NOT_DEFINED",
"modifiedAttackComplexity": "NOT_DEFINED",
"modifiedAttackRequirements": "NOT_DEFINED",
"modifiedAttackVector": "NOT_DEFINED",
"modifiedPrivilegesRequired": "NOT_DEFINED",
"modifiedSubAvailabilityImpact": "NOT_DEFINED",
"modifiedSubConfidentialityImpact": "NOT_DEFINED",
"modifiedSubIntegrityImpact": "NOT_DEFINED",
"modifiedUserInteraction": "NOT_DEFINED",
"modifiedVulnAvailabilityImpact": "NOT_DEFINED",
"modifiedVulnConfidentialityImpact": "NOT_DEFINED",
"modifiedVulnIntegrityImpact": "NOT_DEFINED",
"privilegesRequired": "LOW",
"providerUrgency": "NOT_DEFINED",
"subAvailabilityImpact": "NONE",
"subConfidentialityImpact": "NONE",
"subIntegrityImpact": "NONE",
"userInteraction": "NONE",
"valueDensity": "NOT_DEFINED",
"vectorString": "CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X",
"version": "4.0",
"vulnAvailabilityImpact": "LOW",
"vulnConfidentialityImpact": "HIGH",
"vulnIntegrityImpact": "HIGH",
"vulnerabilityResponseEffort": "NOT_DEFINED"
},
"source": "ics-cert@hq.dhs.gov",
"type": "Secondary"
}
],
"ssvcV203": [
{
"source": "134c704f-9b21-4f2e-91b3-4a467353bcc0",
"ssvcData": {
"id": "CVE-2025-61940",
"options": [
{
"exploitation": "none"
},
{
"automatable": "no"
},
{
"technicalImpact": "total"
}
],
"role": "CISA Coordinator",
"timestamp": "2025-12-09T17:03:20.801749Z",
"version": "2.0.3"
}
}
]
},
"published": "2025-12-02T21:15:51.930",
"references": [
{
"source": "ics-cert@hq.dhs.gov",
"tags": [
"Third Party Advisory"
],
"url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01"
}
],
"sourceIdentifier": "ics-cert@hq.dhs.gov",
"vulnStatus": "Analyzed",
"weaknesses": [
{
"description": [
{
"lang": "en",
"value": "CWE-603"
}
],
"source": "ics-cert@hq.dhs.gov",
"type": "Secondary"
}
]
}
},
"redhat_vex": {
"current_release_date": "2025-12-03T22:02:54+00:00",
"cve": "CVE-2025-61940",
"id": "CVE-2025-61940",
"initial_release_date": "2025-12-02T17:00:00+00:00",
"product_status:known_not_affected": "1",
"source": "Red Hat CSAF VEX",
"status": "final",
"title": "Mirion Medical EC2 Software NMIS BioDose Use of Client-Side Authentication",
"url": "https://security.access.redhat.com/data/csaf/v2/vex/2025/cve-2025-61940.json",
"version": "3"
},
"vulnrichment": {
"containers": {
"adp": [
{
"metrics": [
{
"other": {
"content": {
"id": "CVE-2025-61940",
"options": [
{
"Exploitation": "none"
},
{
"Automatable": "no"
},
{
"Technical Impact": "total"
}
],
"role": "CISA Coordinator",
"timestamp": "2025-12-09T17:03:20.801749Z",
"version": "2.0.3"
},
"type": "ssvc"
}
}
],
"providerMetadata": {
"dateUpdated": "2025-12-02T21:39:24.460Z",
"orgId": "134c704f-9b21-4f2e-91b3-4a467353bcc0",
"shortName": "CISA-ADP"
},
"title": "CISA ADP Vulnrichment"
}
],
"cna": {
"affected": [
{
"defaultStatus": "unaffected",
"product": "EC2 Software NMIS BioDose",
"vendor": "Mirion Medical",
"versions": [
{
"lessThan": "23.0",
"status": "affected",
"version": "0",
"versionType": "custom"
},
{
"status": "unaffected",
"version": "23.0"
}
]
}
],
"credits": [
{
"lang": "en",
"type": "finder",
"value": "Joe Dillon reported these vulnerabilities to Mirion Medical."
}
],
"datePublic": "2025-12-02T17:00:00.000Z",
"descriptions": [
{
"lang": "en",
"supportingMedia": [
{
"base64": false,
"type": "text/html",
"value": "\u003cspan style=\"background-color: rgb(255, 255, 255);\"\u003e\n\n\u003cspan style=\"background-color: rgb(255, 255, 255);\"\u003e\n\n\u003cspan style=\"background-color: rgb(255, 255, 255);\"\u003eNMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.\u003c/span\u003e\n\n\u003c/span\u003e\n\n\u003c/span\u003e"
}
],
"value": "NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection."
}
],
"metrics": [
{
"cvssV4_0": {
"Automatable": "NOT_DEFINED",
"Recovery": "NOT_DEFINED",
"Safety": "NOT_DEFINED",
"attackComplexity": "LOW",
"attackRequirements": "NONE",
"attackVector": "NETWORK",
"baseScore": 8.7,
"baseSeverity": "HIGH",
"exploitMaturity": "NOT_DEFINED",
"privilegesRequired": "LOW",
"providerUrgency": "NOT_DEFINED",
"subAvailabilityImpact": "NONE",
"subConfidentialityImpact": "NONE",
"subIntegrityImpact": "NONE",
"userInteraction": "NONE",
"valueDensity": "NOT_DEFINED",
"vectorString": "CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N",
"version": "4.0",
"vulnAvailabilityImpact": "LOW",
"vulnConfidentialityImpact": "HIGH",
"vulnIntegrityImpact": "HIGH",
"vulnerabilityResponseEffort": "NOT_DEFINED"
},
"format": "CVSS",
"scenarios": [
{
"lang": "en",
"value": "GENERAL"
}
]
},
{
"cvssV3_1": {
"attackComplexity": "LOW",
"attackVector": "NETWORK",
"availabilityImpact": "LOW",
"baseScore": 8.3,
"baseSeverity": "HIGH",
"confidentialityImpact": "HIGH",
"integrityImpact": "HIGH",
"privilegesRequired": "LOW",
"scope": "UNCHANGED",
"userInteraction": "NONE",
"vectorString": "CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L",
"version": "3.1"
},
"format": "CVSS",
"scenarios": [
{
"lang": "en",
"value": "GENERAL"
}
]
}
],
"problemTypes": [
{
"descriptions": [
{
"cweId": "CWE-603",
"description": "CWE-603",
"lang": "en",
"type": "CWE"
}
]
}
],
"providerMetadata": {
"dateUpdated": "2025-12-02T21:07:47.995Z",
"orgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
"shortName": "icscert"
},
"references": [
{
"url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01"
}
],
"solutions": [
{
"lang": "en",
"supportingMedia": [
{
"base64": false,
"type": "text/html",
"value": "\u003cspan style=\"background-color: rgb(255, 255, 255);\"\u003eMirion Medical recommends users update to V23.0 or later. Users with an active support contract should update to the latest version through the software or users can contact \u003c/span\u003e\u003ca target=\"_blank\" rel=\"nofollow\"\u003eMirion Medical support\u003c/a\u003e\u003cspan style=\"background-color: rgb(255, 255, 255);\"\u003e\u0026nbsp;directly.\u003c/span\u003e\n\n\u003cbr\u003e"
}
],
"value": "Mirion Medical recommends users update to V23.0 or later. Users with an active support contract should update to the latest version through the software or users can contact Mirion Medical support\u00a0directly."
}
],
"source": {
"advisory": "ICSMA-25-336-01",
"discovery": "EXTERNAL"
},
"title": "Mirion Medical EC2 Software NMIS BioDose Use of Client-Side Authentication",
"x_generator": {
"engine": "Vulnogram 0.5.0"
}
}
},
"cveMetadata": {
"assignerOrgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
"assignerShortName": "icscert",
"cveId": "CVE-2025-61940",
"datePublished": "2025-12-02T21:07:47.995Z",
"dateReserved": "2025-11-11T20:56:52.843Z",
"dateUpdated": "2025-12-09T17:03:27.576Z",
"state": "PUBLISHED"
},
"dataType": "CVE_RECORD",
"dataVersion": "5.2"
}
}
}
Drag nodes to arrange them. Double-click a related vulnerability to open it, or a source to visit its link. The Physics button on the left tunes the layout and the simulation; the legend at the bottom left hides or shows nodes by kind and by sighting type.
Sightings
| Author | Source | Type | Date | Other |
|---|
Nomenclature
- Seen: The vulnerability was mentioned, discussed, or observed by the user.
- Confirmed: The vulnerability has been validated from an analyst's perspective.
- Published Proof of Concept: A public proof of concept is available for this vulnerability.
- Exploited: The vulnerability was observed as exploited by the user who reported the sighting.
- Patched: The vulnerability was observed as successfully patched by the user who reported the sighting.
- Not exploited: The vulnerability was not observed as exploited by the user who reported the sighting.
- Not confirmed: The user expressed doubt about the validity of the vulnerability.
- Not patched: The vulnerability was not observed as successfully patched by the user who reported the sighting.
Vulnerability timeline
Sightings and recorded dates, grouped by day · UTC
How durations are calculated
Following the VTEM framework (Black Hat USA 2015), time to patch starts when the vendor or a coordinator was informed, total time to patch at discovery, and disclosure to patch at public disclosure; vendor response time runs from the report to its acknowledgement. Time to exploit and time unpatched start at the earliest discovery or report, falling back to public disclosure. Unpatched time ends at the first recorded patch, or the calculation time when no patch is recorded. Exploitation to patch shows the interval between those two events; a published proof of concept is a public exploit, not exploitation.
Each result shows its source dates. A negative interval means the end event came first; when date-only inputs leave the order open, the result says so. Date-only inputs are approximate. The earliest evidence wins: KEV report dates and sightings are labelled as such. Records describing another vulnerability are listed but never calculated from, and a PoC alone does not establish exploitation. Missing patch evidence does not prove that no patch exists. Filters below change the event list only.
Loading timeline…
The approach is described in our paper Mapping CVEs to MITRE ATT&CK Techniques: A Curated Gold-Set Classifier and the Limits of LLM-Assisted Label Expansion.
Browse all ATT&CK techniques and the vulnerabilities related to each.
Related by attack behaviour
Vulnerabilities whose description is nearest to this one in the vector space of the CIRCL/vulnerability-attack-technique-biencoder model. This is a similarity search over the bi-encoder space (plain cosine), not a classification, and it has no measured accuracy.